PATENT CLAIM ANALYSIS

Application Number: 15884594
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2019-02
Patent Classification: ["514", "019300"]

Abstract:
Provided herein are consensus amino acid sequences of prostate antigens that are capable of breaking tolerance in a targeted species, including PSA, PSMA, STEAP and PSCA antigens. Also provided are nucleic acid sequences that encode one or more consensus amino acid sequences of prostate antigens PSA, PSMA, STEAP and PSCA, as well as genetic constructs/vectors and vaccines expressing the sequences. Also provided herein are methods for generating an autoimmune response against prostate cancer cells by administering one or more of the vaccines, proteins, and/or nucleic acid sequences that are provided.

Claim (Index 7):
The nucleic acid molecule of  claim 6  comprising one or more nucleotide sequences selected from the group comprising: elements a), b), c), or d).

Metadata:
- Claim Count in Document: 49.0
- Percentile: 86.0
- Lexical Diversity: 1.90566
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14552030', '15207271', '13883978', '15213747', '14978329']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8103865721055872
- 35 USC 102 Novelty (BERT): 0.6426678075871197
- Combined Prediction Score: 0.7936146956537404
- Mean Citation Score: 484.19130600000005
- Max Citation Score: 594.07654
- Similarity Product: 573.2058379040599

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test